192 related articles for article (PubMed ID: 22016416)
1. Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A.
Pietrowski D; Szabo L; Sator M; Just A; Egarter C
Hum Reprod; 2012 Jan; 27(1):196-9. PubMed ID: 22016416
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
Pau E; Alonso-Muriel I; Gómez R; Novella E; Ruiz A; García-Velasco JA; Simón C; Pellicer A
Hum Reprod; 2006 Jun; 21(6):1453-60. PubMed ID: 16488907
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women.
Molskness TA; Stouffer RL; Burry KA; Gorrill MJ; Lee DM; Patton PE
Hum Reprod; 2004 Apr; 19(4):822-30. PubMed ID: 15033950
[TBL] [Abstract][Full Text] [Related]
4. Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment.
Jaroszewicz J; Januszkiewicz M; Flisiak R; Rogalska M; Kalinowska A; Wierzbicka I
Cytokine; 2008 Oct; 44(1):14-7. PubMed ID: 18656381
[TBL] [Abstract][Full Text] [Related]
5. Serum vascular endothelial growth factor and its receptor level in patients with chronic obstructive pulmonary disease.
Kierszniewska-Stepień D; Pietras T; Górski P; Stepien H
Eur Cytokine Netw; 2006 Mar; 17(1):75-9. PubMed ID: 16613766
[TBL] [Abstract][Full Text] [Related]
6. [The Predictive Role of Vascular Endothelial Growth Factor and Estradiol in Infertile Patients with Ovarian Hyperstimulation Syndrome].
Wang Q; Yang G; Yang C; Zhan B; Yang R
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):565-7. PubMed ID: 12910723
[TBL] [Abstract][Full Text] [Related]
7. High levels of soluble vascular endothelial growth factor receptor 1/sFlt1 and low levels of vascular endothelial growth factor in follicular fluid on the day of oocyte retrieval correlate with ovarian hyperstimulation syndrom regardless of the stimulation protocol.
Jakimiuk AJ; Nowicka MA; Zagozda M; Koziol K; Lewandowski P; Issat T
J Physiol Pharmacol; 2017 Jun; 68(3):477-484. PubMed ID: 28820403
[TBL] [Abstract][Full Text] [Related]
8. Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come.
Aref S; El Sherbiny M; Goda T; Fouda M; Al Askalany H; Abdalla D
Hematology; 2005 Apr; 10(2):131-4. PubMed ID: 16019458
[TBL] [Abstract][Full Text] [Related]
9. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?
Geva E; Amit A; Lessing JB; Lerner-Geva L; Daniel Y; Yovel I; Azem F; Barak V
J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438
[TBL] [Abstract][Full Text] [Related]
10. Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
Villasante A; Pacheco A; Pau E; Ruiz A; Pellicer A; Garcia-Velasco JA
Hum Reprod; 2008 Mar; 23(3):662-7. PubMed ID: 18216038
[TBL] [Abstract][Full Text] [Related]
11. Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability.
Gómez R; Simón C; Remohí J; Pellicer A
Biol Reprod; 2003 Jun; 68(6):2164-71. PubMed ID: 12606463
[TBL] [Abstract][Full Text] [Related]
12. Effects of gonadotropin-releasing hormone antagonists on the expression of vascular endothelial growth factor and its receptors in a rat model of ovarian hyperstimulation syndrome.
Tong XM; Zhang SY; Song T; Xu WH; Lin XN; Shu J; Liu L
Chin Med J (Engl); 2008 Dec; 121(23):2434-9. PubMed ID: 19102964
[TBL] [Abstract][Full Text] [Related]
13. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
[TBL] [Abstract][Full Text] [Related]
14. [Function of vascular endothelial growth factor in ovarian hyperstimulation syndrome].
Liang W; Chen S; Xing F
Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):651-3. PubMed ID: 11930687
[TBL] [Abstract][Full Text] [Related]
15. Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations.
Flisiak I; Zaniewski P; Rogalska-Taranta M; Chodynicka B
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):302-7. PubMed ID: 21418334
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary study on the role of vascular endothelial growth factor in pathogenesis of ovarian hyperstimulation syndrome].
Zhou C; Yu C; Zhuang G
Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):654-6. PubMed ID: 11930688
[TBL] [Abstract][Full Text] [Related]
17. Disruption of components of vascular endothelial growth factor angiogenic signalling system in metabolic syndrome. Findings from a study conducted in rural Bangladeshi women.
Jesmin S; Akter S; Rahman MM; Islam MM; Islam AM; Sultana SN; Mowa CN; Yamaguchi N; Okazaki O; Satoru K; Kimura S; Hiroe M; Mizutani T; Moroi M
Thromb Haemost; 2013 Apr; 109(4):696-705. PubMed ID: 23364276
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF.
Manau D; Fábregues F; Peñarrubia J; Creus M; Carmona F; Casals G; Jiménez W; Balasch J
Hum Reprod; 2007 Mar; 22(3):669-75. PubMed ID: 17079244
[TBL] [Abstract][Full Text] [Related]
19. Signal mechanisms of vascular endothelial growth factor and interleukin-8 in ovarian hyperstimulation syndrome: dopamine targets their common pathways.
Chen SU; Chou CH; Lin CW; Lee H; Wu JC; Lu HF; Chen CD; Yang YS
Hum Reprod; 2010 Mar; 25(3):757-67. PubMed ID: 20008399
[TBL] [Abstract][Full Text] [Related]
20. Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model.
Gomez R; Gonzalez-Izquierdo M; Zimmermann RC; Novella-Maestre E; Alonso-Muriel I; Sanchez-Criado J; Remohi J; Simon C; Pellicer A
Endocrinology; 2006 Nov; 147(11):5400-11. PubMed ID: 16901966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
